Overview

A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare the adhesiveness of 2 different patch formulations of Rotigotine using the largest patch size of 40 cm^2, under the assumption that both patch formulations show similar adhesiveness properties.
Phase:
Phase 1
Details
Lead Sponsor:
UCB BIOSCIENCES GmbH
Collaborators:
Bracket Global
Pharmaceutical Health Sciences
Treatments:
N 0437
Rotigotine